Plain-English translation of NCT06998745 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After colorectal cancer surgery, patients often need blood thinners to prevent dangerous blood clots. This study tests whether a special pharmacy care program—called Medication Therapy Management (MTM)—helps doctors and pharmacists manage these medications more safely and effectively. The program provides personalized support when you're admitted to the hospital, during your stay, and after you go home.
Blood thinners are powerful medications that prevent clots but can also cause serious bleeding. Many patients either take these medications incorrectly, stop taking them too early, or don't get enough support managing them—all of which can lead to dangerous complications. This study wants to see if dedicated pharmacist support can solve these problems and keep patients safer.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will either receive standard care from your regular doctors or be assigned to the pharmacy care program (MTM model), where a pharmacist will work with your medical team to monitor and adjust your blood thinner medication throughout your hospital stay and after discharge. The pharmacist will help ensure your medication is working properly and watch for any signs of bleeding or clots. The study will track your health outcomes over time to see which approach is safer and more effective.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
China